Public Employees Retirement Association of Colorado
RNA

Public Employees Retirement Association of Colorado’s Atrium Therapeutics RNA Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-780
Closed -$10K – 1886
2026
Q1 		$10K Buy
+780
New +$11K ﹤0.01% 1843

Other funds holding RNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $190M AUM 51.6% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Public Employees Retirement Association of Colorado's RNA Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado sold out of Atrium Therapeutics (RNA) in Q2 2026, closing a stake of 780 shares — an estimated $10K sold.

Public Employees Retirement Association of Colorado first reported a position in RNA in Q1 2026 and held it in 1 quarter. The position peaked at $10K in Q1 2026. 54 funds tracked by Wall St. Rank hold RNA as of Q2 2026.

  • Public Employees Retirement Association of Colorado reported no remaining Atrium Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 780 Atrium Therapeutics shares in Q2 2026, an estimated $10K.
  • Public Employees Retirement Association of Colorado first reported a position in Atrium Therapeutics in Q1 2026 and held it in 1 quarter.
  • Public Employees Retirement Association of Colorado's Atrium Therapeutics position peaked at $10K in Q1 2026.
  • 54 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.